News

Consumers rely on prevention

BY Michael Johnsen

Consumers buying hand sanitizer are shopping the set multiple times because of different needs, noted Tim Cleary, VP sales at Purell Consumer, suggesting there may be a latent opportunity for the already-growing Purell Advanced formula, which generated $20.6 million in sales, up 25.2%, for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI. In the cough-cold set, it’s about not getting sick. “Use it three times a day and you can reduce the chance of illness in your household by 25%,” Cleary said.

(For the complete category review, including data, click here.)

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Mucinex taps nighttime market

BY Michael Johnsen

Reckitt Benckiser this season extended its line of popular Mucinex Fast-Max products, which provide multi-symptom relief, to include a product for nighttime cold-and-flu relief in both liquid and tablet form, taking on Procter & Gamble’s NyQuil franchise.

(For the complete category review, including data, click here.)

According to Reckitt Benckiser, nighttime relief is a $600 million market in the United States, and Mucinex Fast-Max is differentiated from its competitors because it contains an active ingredient for nasal decongestion.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Sales decline exceeds projections

BY Michael Johnsen

While nobody thought 2013-14 cough-cold sales would reach as high in comparison to the year before, no one expected the season to come down as much as it did. “If you recall, last year cough-cold really raged from mid-December … up until the beginning of February,” said Matthew Mannelly, CEO, president and director of Prestige Brands, in discussing the season with analysts. “If you look at retailers and other manufacturers, the season is not panning out. Candidly, I think the retailers are not reordering and are now gearing up for the [spring] allergy season,” he said at the close of the season.

(For the complete category review, including data, click here.)

That may explain why many retailers are focusing on prevention. Both flu shots and products focused on preventive care are performing extremely well. Walgreens administered 6.7 million immunizations in its first quarter, up 34% as compared with the year-ago period. And Airborne generated $117.1 million across total U.S. multi-outlets for the 52 weeks ended May 18, according to IRI, benefiting from a lift of 16.5%.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?